Obstetric Complications Common Among Women Who Develop Systemic Sclerosis
Researchers evaluated obstetric complications in women with a systemic sclerosis diagnosis vs the general obstetric population.
Researchers evaluated obstetric complications in women with a systemic sclerosis diagnosis vs the general obstetric population.
The performance of 5 core set measure in ACR-CRISS in recent trials was explored, and their ability to discern the active medication group from placebo in patients with diffuse cutaneous systemic sclerosis (dcSSc), was assessed.
Close monitoring of patients with systemic sclerosis-associated interstitial lung disease and awareness of the variable course of progression is highly important in considering when to initiate treatment.
In this open-label extension study, researchers reported on the safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis.
Study authors analyzed the effects of nintedanib on changes in forced vital capacity and other measures of progression in systemic sclerosis-associated interstitial lung disease.
ACE-1334 is a TGF-beta superfamily-based ligand trap designed to bind and inhibit TGF-beta 1 and 3 ligands.
The British Society for Rheumatology released consensus-based recommendations for the management of juvenile systemic sclerosis.
Study authors determined the performance of pulmonary screening vs HRCT in detecting interstitial lung disease in juvenile SSc.
Researchers evaluated the contribution of abnormal GI transit to systemic sclerosis Medsger GI severity scores and/or UCLA GIT 2.0 symptoms.
The long-term safety and efficacy of tocilizumab in patients with systemic sclerosis were assessed in an open-label study.